SI0804479T1 - Metoda zdravljenja sladkorne bolezni z uporabo kgf - Google Patents

Metoda zdravljenja sladkorne bolezni z uporabo kgf

Info

Publication number: SI0804479T1
Authority: SI; Slovenia
Prior art keywords: kgf; diabetes mellitus; treating diabetes; mammals; pharmaceutical compositions
Prior art date: 1994-10-13

Application number

SI9530728T

Other languages

English (en)

Inventor

Sharon Lea Aukerman

Glenn Francis Pierce

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-13

Filing date

1995-10-12

Publication date

2006-12-31

1995-10-12 Application filed by Amgen Inc filed Critical Amgen Inc

2006-12-31 Publication of SI0804479T1 publication Critical patent/SI0804479T1/sl

Links

206010012601 diabetes mellitus Diseases 0.000 title abstract 2
102000003972 Fibroblast growth factor 7 Human genes 0.000 abstract 1
108090000385 Fibroblast growth factor 7 Proteins 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Zoology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

SI9530728T 1994-10-13 1995-10-12 Metoda zdravljenja sladkorne bolezni z uporabo kgf SI0804479T1 (sl)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US32347594A	1994-10-13	1994-10-13
US32334094A	1994-10-13	1994-10-13
US48782595A	1995-06-07	1995-06-07
PCT/IB1995/000992 WO1996011950A1 (en)	1994-10-13	1995-10-12	Method of treating diabetes mellitus using kgf
EP95934808A EP0804479B1 (en)	1994-10-13	1995-10-12	Method of treating diabetes mellitus using kgf

Publications (1)

Publication Number	Publication Date
SI0804479T1 true SI0804479T1 (sl)	2006-12-31

Family

ID=27406268

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SI9530728T SI0804479T1 (sl)	1994-10-13	1995-10-12	Metoda zdravljenja sladkorne bolezni z uporabo kgf
SI9530654T SI0785948T1 (sl)	1994-10-13	1995-10-12	Analogi keratinocitnega rastnega faktorja

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SI9530654T SI0785948T1 (sl)	1994-10-13	1995-10-12	Analogi keratinocitnega rastnega faktorja

Country Status (23)

Country	Link
EP (2)	EP0785948B1 (sl)
JP (2)	JP4216329B2 (sl)
KR (1)	KR100278597B1 (sl)
CN (1)	CN1168678A (sl)
AT (2)	ATE237633T1 (sl)
AU (1)	AU3707795A (sl)
BG (2)	BG101392A (sl)
BR (2)	BR9509269A (sl)
CA (2)	CA2202075C (sl)
CZ (3)	CZ98197A3 (sl)
DE (2)	DE69530403T2 (sl)
DK (2)	DK0804479T3 (sl)
EE (2)	EE9700225A (sl)
ES (2)	ES2273338T3 (sl)
FI (2)	FI971420A0 (sl)
HU (2)	HUT78050A (sl)
NO (2)	NO318761B1 (sl)
NZ (2)	NZ505502A (sl)
PL (2)	PL320484A1 (sl)
PT (2)	PT804479E (sl)
SI (2)	SI0804479T1 (sl)
SK (2)	SK43197A3 (sl)
WO (2)	WO1996011949A2 (sl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU647732B2 (en)	1989-01-31	1994-03-31	Stuart A. Aaronson	DNA encoding a growth factor specific for epithelial cells
CN1129955A (zh)	1993-06-29	1996-08-28	奇龙公司	截短的生物活性更高的角质形成细胞生长因子
US7084119B2 (en)	1993-06-29	2006-08-01	Chiron Corporation	Truncated keratinocyte growth factor (KGF) having increased biological activity
DK0785949T3 (da) *	1994-10-13	2003-08-18	Amgen Inc	Fremgangsmåde til oprensning af keratinocytvækstfaktorer
US6693077B1 (en)	1995-02-14	2004-02-17	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US7232667B2 (en)	1995-02-14	2007-06-19	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 polynucleotides
US6077692A (en) *	1995-02-14	2000-06-20	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
WO1996034017A1 (en) *	1995-04-27	1996-10-31	Coöperatie Suiker Unie U.A.	Inulin derivatives
US6743422B1 (en)	1996-10-15	2004-06-01	Amgen, Inc.	Keratinocyte growth factor-2 products
AU727678C (en) *	1996-10-15	2005-05-12	Biovitrum Ab (Publ)	Keratinocyte growth factor-2 products
EP1473366A1 (en) *	1996-10-15	2004-11-03	Amgen Inc.	Keratinocyte growth factor-2 products
US20080076706A1 (en)	1997-07-14	2008-03-27	Bolder Biotechnology, Inc.	Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
WO2000042175A1 (en) *	1999-01-14	2000-07-20	Bolder Biotechnology Inc.	Methods for making proteins containing free cysteine residues
US7153943B2 (en)	1997-07-14	2006-12-26	Bolder Biotechnology, Inc.	Derivatives of growth hormone and related proteins, and methods of use thereof
IL133974A0 (en)	1997-07-14	2001-04-30	Bolder Biotechnology Inc	Derivatives of growth hormone and related proteins
US7495087B2 (en)	1997-07-14	2009-02-24	Bolder Biotechnology, Inc.	Cysteine muteins in the C-D loop of human interleukin-11
US6869927B1 (en)	1997-12-22	2005-03-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
JP2001526239A (ja)	1997-12-22	2001-12-18	ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド	角質細胞増殖因子−２製剤
US6242666B1 (en) *	1998-12-16	2001-06-05	The Scripps Research Institute	Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
US8288126B2 (en)	1999-01-14	2012-10-16	Bolder Biotechnology, Inc.	Methods for making proteins containing free cysteine residues
US6248725B1 (en)	1999-02-23	2001-06-19	Amgen, Inc.	Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
US20040063634A1 (en) *	2001-01-19	2004-04-01	Carr Francis J.	Modified kertinocyte growth factor (kgf) with reduced immunogenicity
CA2457781A1 (en) *	2001-08-21	2003-02-27	Chiron Corporation	Kgf polypeptide compositions
AU2007214362B2 (en) *	2001-08-21	2009-11-26	Novartis Vaccines And Diagnostics, Inc.	KGF polypeptide compositions
PL1827483T3 (pl)	2004-12-15	2014-12-31	Swedish Orphan Biovitrum Ab Publ	Formulacje terapeutyczne czynnika wzrostu keratynocytów
CN102242124B (zh) *	2010-05-10	2013-05-22	齐鲁制药有限公司	改造的角化细胞生长因子基因及其在酵母中的表达
KR102440312B1 (ko) *	2020-08-28	2022-09-05	한국해양과학기술원	온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4959314A (en) *	1984-11-09	1990-09-25	Cetus Corporation	Cysteine-depleted muteins of biologically active proteins
JPH01137994A (ja) *	1987-08-10	1989-05-30	Shionogi & Co Ltd	ｒｅｇ蛋白質
WO1990000877A1 (en) *	1988-07-27	1990-02-08	Marjan International Pty Ltd	Carpet stretcher
AU647732B2 (en) *	1989-01-31	1994-03-31	Stuart A. Aaronson	DNA encoding a growth factor specific for epithelial cells
JP3303211B2 (ja) *	1991-04-26	2002-07-15	武田薬品工業株式会社	ｂＦＧＦムテインおよびその製造法
JP3578761B2 (ja) *	1993-03-26	2004-10-20	アムジエン・インコーポレーテツド	表皮ケラチン細胞成長因子の治療目的での使用
US5348563A (en) *	1993-06-29	1994-09-20	Honeywell Inc.	Air purifying apparatus
CN1129955A (zh) *	1993-06-29	1996-08-28	奇龙公司	截短的生物活性更高的角质形成细胞生长因子
GB9315501D0 (en) *	1993-07-27	1993-09-08	Ici Plc	Surfactant compositions
AU7475694A (en) *	1993-08-02	1995-02-28	Prizm Pharmaceuticals, Inc.	Monogenous preparations of cytotoxic conjugates

1995
- 1995-10-12 EP EP95934793A patent/EP0785948B1/en not_active Expired - Lifetime
- 1995-10-12 AT AT95934793T patent/ATE237633T1/de active
- 1995-10-12 HU HU9901071A patent/HUT78050A/hu unknown
- 1995-10-12 EE EE9700225A patent/EE9700225A/xx unknown
- 1995-10-12 CA CA002202075A patent/CA2202075C/en not_active Expired - Fee Related
- 1995-10-12 CZ CZ97981A patent/CZ98197A3/cs unknown
- 1995-10-12 EP EP95934808A patent/EP0804479B1/en not_active Expired - Lifetime
- 1995-10-12 BR BR9509269A patent/BR9509269A/pt not_active Application Discontinuation
- 1995-10-12 ES ES95934808T patent/ES2273338T3/es not_active Expired - Lifetime
- 1995-10-12 KR KR1019970702343A patent/KR100278597B1/ko not_active IP Right Cessation
- 1995-10-12 ES ES95934793T patent/ES2196082T3/es not_active Expired - Lifetime
- 1995-10-12 DK DK95934808T patent/DK0804479T3/da active
- 1995-10-12 NZ NZ505502A patent/NZ505502A/en not_active IP Right Cessation
- 1995-10-12 SI SI9530728T patent/SI0804479T1/sl unknown
- 1995-10-12 BR BR9509329A patent/BR9509329A/pt not_active Application Discontinuation
- 1995-10-12 HU HU9901255A patent/HU226168B1/hu not_active IP Right Cessation
- 1995-10-12 CA CA002201940A patent/CA2201940C/en not_active Expired - Fee Related
- 1995-10-12 CZ CZ20023953A patent/CZ297329B6/cs not_active IP Right Cessation
- 1995-10-12 WO PCT/IB1995/000971 patent/WO1996011949A2/en active IP Right Grant
- 1995-10-12 CZ CZ0105097A patent/CZ297328B6/cs not_active IP Right Cessation
- 1995-10-12 SK SK431-97A patent/SK43197A3/sk unknown
- 1995-10-12 AT AT95934808T patent/ATE342278T1/de active
- 1995-10-12 PT PT95934808T patent/PT804479E/pt unknown
- 1995-10-12 AU AU37077/95A patent/AU3707795A/en not_active Abandoned
- 1995-10-12 EE EE9700081A patent/EE03975B1/xx not_active IP Right Cessation
- 1995-10-12 WO PCT/IB1995/000992 patent/WO1996011950A1/en active IP Right Grant
- 1995-10-12 PL PL95320484A patent/PL320484A1/xx unknown
- 1995-10-12 DK DK95934793T patent/DK0785948T3/da active
- 1995-10-12 CN CN95196410A patent/CN1168678A/zh active Pending
- 1995-10-12 PL PL95319784A patent/PL182888B1/pl not_active IP Right Cessation
- 1995-10-12 JP JP51307796A patent/JP4216329B2/ja not_active Expired - Fee Related
- 1995-10-12 DE DE69530403T patent/DE69530403T2/de not_active Expired - Lifetime
- 1995-10-12 PT PT95934793T patent/PT785948E/pt unknown
- 1995-10-12 SK SK455-97A patent/SK284534B6/sk not_active IP Right Cessation
- 1995-10-12 SI SI9530654T patent/SI0785948T1/sl unknown
- 1995-10-12 DE DE69535264T patent/DE69535264T2/de not_active Expired - Lifetime
- 1995-10-12 JP JP51307696A patent/JP4426646B2/ja not_active Expired - Fee Related
1997
- 1997-04-04 NO NO19971568A patent/NO318761B1/no not_active IP Right Cessation
- 1997-04-04 FI FI971420A patent/FI971420A0/fi unknown
- 1997-04-04 NO NO971566A patent/NO971566L/no unknown
- 1997-04-07 BG BG101392A patent/BG101392A/xx unknown
- 1997-04-11 BG BG101408A patent/BG63167B1/bg unknown
- 1997-04-11 FI FI971536A patent/FI120040B/fi not_active IP Right Cessation
1999
- 1999-04-09 NZ NZ335109A patent/NZ335109A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
HUT78050A (hu)	1999-07-28
HU226168B1 (en)	2008-05-28
NO971566L (no)	1997-04-14
CZ297328B6 (cs)	2006-11-15
ES2273338T3 (es)	2007-05-01
CZ105097A3 (cs)	1998-10-14
EP0785948B1 (en)	2003-04-16
AU3707795A (en)	1996-05-06
DK0804479T3 (da)	2007-01-29
BG101392A (en)	1997-10-31
DE69535264T2 (de)	2007-02-01
FI971420A (fi)	1997-04-04
WO1996011949A2 (en)	1996-04-25
NZ505502A (en)	2005-01-28
CZ297329B6 (cs)	2006-11-15
EP0785948A1 (en)	1997-07-30
PT804479E (pt)	2007-02-28
ATE342278T1 (de)	2006-11-15
CZ98197A3 (cs)	1998-11-11
DE69535264D1 (de)	2006-11-23
NO971568D0 (no)	1997-04-04
JPH10507080A (ja)	1998-07-14
BG101408A (en)	1997-12-30
SK45597A3 (en)	1999-02-11
NO318761B1 (no)	2005-05-02
CN1168678A (zh)	1997-12-24
ES2196082T3 (es)	2003-12-16
FI120040B (fi)	2009-06-15
DE69530403D1 (de)	2003-05-22
SI0785948T1 (sl)	2003-08-31
CA2202075C (en)	2003-12-09
DE69530403T2 (de)	2003-10-30
EE9700225A (et)	1998-02-16
EP0804479A1 (en)	1997-11-05
BR9509269A (pt)	1997-12-23
PL182888B1 (pl)	2002-03-29
ATE237633T1 (de)	2003-05-15
JP4216329B2 (ja)	2009-01-28
BR9509329A (pt)	1997-10-14
NO971566D0 (no)	1997-04-04
FI971536A0 (fi)	1997-04-11
NO971568L (no)	1997-06-12
JP4426646B2 (ja)	2010-03-03
PT785948E (pt)	2003-09-30
EE9700081A (et)	1997-10-15
CA2201940A1 (en)	1996-04-25
JPH10507193A (ja)	1998-07-14
BG63167B1 (bg)	2001-05-31
FI971420A0 (fi)	1997-04-04
SK43197A3 (en)	1999-03-12
EP0804479B1 (en)	2006-10-11
EE03975B1 (et)	2003-02-17
FI971536A (fi)	1997-06-09
NZ335109A (en)	2000-08-25
HUT78058A (hu)	1999-07-28
PL320484A1 (en)	1997-09-29
PL319784A1 (en)	1997-08-18
AU3708395A (en)	1996-05-06
CA2202075A1 (en)	1996-04-25
CA2201940C (en)	2009-05-12
WO1996011950A1 (en)	1996-04-25
WO1996011949A3 (en)	1996-12-12
SK284534B6 (sk)	2005-06-02
KR100278597B1 (ko)	2001-01-15
AU681546B2 (en)	1997-08-28
DK0785948T3 (da)	2003-08-04

Publication	Publication Date	Title
BG101392A (en)	1997-10-31	Method of treating diabetes mellitus using kgf
AU1128297A (en)	1997-06-27	Composition for treating pain
AU5287090A (en)	1990-09-26	Method and composition for treatment of periodontal disease
GB9410639D0 (en)	1994-07-13	Method of improving fertilization
AU7793791A (en)	1991-11-27	Pharmaceutical composition for use in treating pain
DE69110861D1 (de)	1995-08-03	Mittel zur verbesserung des kollagenmetabolismus und dessen verwendung.
AUPM836794A0 (en)	1994-10-20	Improved method and composition for the treatment of ulcers
HU9503331D0 (en)	1996-01-29	Process for treating ill people with oxygen
DE69534740D1 (en)	2006-04-06	Analoge des thymosin alpha 1
UA15363A (uk)	1997-06-30	Засіб для лікуваhhя відкритих пошкоджеhь
AU3597695A (en)	1996-04-09	Improved method and composition for the treatment of ulcers
AUPN733195A0 (en)	1996-01-25	Improved method and composition for the treatment of ulcers
AU6459996A (en)	1997-02-10	Composition and method for treating diabetes
IL101313A0 (en)	1992-11-15	Compositions and methods for increasing oxygen delivery to tissue
GB9421321D0 (en)	1994-12-07	Composition for the treatment of gastro-duodenal ulcers
HUT72420A (en)	1996-04-29	Composition for treating diabetes and process for treating the same
GB9522247D0 (en)	1996-01-03	Composition for the treatment of gastra-duodenal ulcers
HU9402028D0 (en)	1994-09-28	Creme for treating feet of patients in diabetes